Global Markets Direct: Market Research Reports

Global Markets Direct is a cutting-edge provider of market research and business consultancies for a wide range of customers worldwide.

A team of analytics is capable to produce all sorts of market information and carry out extensive industry research using unique data and reliable sources to let customers know who they are at the market. Global Markets Direct has profound analytical experience in researching the industries and preparing customized reports across many specific fields.

The company is distinguished by its high-quality consulting products and close inspection of the issues under study. Diligent efforts of the experts make every piece of business information an exclusive source of feasible solutions and valuable advice.

With a commitment to serve every client need, Global Markets Direct collects and interprets the materials for the analysis, uses methods of primary and secondary research and develops one of a kind data packages for global clients. They are able to cover the tones of industry-related information to assist customers in taking the right business decisions and developing their strategic plans.

Under the supervision of skillful managers and experts, business analysts produce reports that include:

Product portfolio
Potentially strong market reviews
Competitive analytics
Prospect partners
Mergers and acquisitions project data
Latest trends across a particular industry area
Research and development strategies
The analysis of new customers
A set of remedial measures for projects

They will search for new partners and highlight the current business issues plus develop new strategies and tactical steps to help you take the lead in the industry where you operate.

Publications found: 5,853

Sort by:

Ageing Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Ageing Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Ageing Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overvi...

May 2022 86 pages

Aicardi-Goutieres Syndrome (AGS) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Aicardi-Goutieres Syndrome (AGS) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Aicardi-Goutieres Syndrome (AGS) Drugs in Development by Stages, Target, MoA, R...

May 2022 37 pages

Aldehyde Dehydrogenase Mitochondrial (ALDH Class 2 or ALDH E2 or ALDHI or ALDH2 or EC 1.2.1.3) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Aldehyde Dehydrogenase Mitochondrial (ALDH Class 2 or ALDH E2 or ALDHI or ALDH2 or EC 1.2.1.3) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SU...

May 2022 37 pages

Aldose Reductase (Aldehyde Reductase or Aldo Keto Reductase Family 1 Member B1 or AKR1B1 or EC 1.1.1.21) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Aldose Reductase (Aldehyde Reductase or Aldo Keto Reductase Family 1 Member B1 or AKR1B1 or EC 1.1.1.21) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key...

May 2022 36 pages

ALK Tyrosine Kinase Receptor (Anaplastic Lymphoma Kinase or CD246 or ALK or EC 2.7.10.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

ALK Tyrosine Kinase Receptor (Anaplastic Lymphoma Kinase or CD246 or ALK or EC 2.7.10.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY...

May 2022 67 pages

Alkaline Phosphatase (ALKP or Phosphomonoesterase or Glycerophosphatase or Alkaline Phosphohydrolase or EC 3.1.3.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Alkaline Phosphatase (ALKP or Phosphomonoesterase or Glycerophosphatase or Alkaline Phosphohydrolase or EC 3.1.3.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Ty...

May 2022 40 pages

Allergic Asthma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Allergic Asthma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Allergic Asthma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players...

May 2022 97 pages

Allergic Bronchopulmonary Aspergillosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Allergic Bronchopulmonary Aspergillosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Allergic Bronchopulmonary Aspergillosis Drugs in Development by Stages,...

May 2022 37 pages

Allergic Rhino-Conjunctivitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Allergic Rhino-Conjunctivitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Allergic Rhino-Conjunctivitis Drugs in Development by Stages, Target, MoA, RoA, Mo...

May 2022 43 pages

Alopecia Areata Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Alopecia Areata Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Alopecia Areata Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players...

May 2022 60 pages

Alpha 1 Adrenergic Receptor (ADRA1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Alpha 1 Adrenergic Receptor (ADRA1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Alpha 1 Adrenergic Receptor (ADRA1) Drugs in Developm...

May 2022 67 pages

Alpha 1 Antitrypsin (Alpha 1 Protease Inhibitor or Alpha 1 Antiproteinase or SERPINA1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Alpha 1 Antitrypsin (Alpha 1 Protease Inhibitor or Alpha 1 Antiproteinase or SERPINA1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Al...

May 2022 64 pages

Alpha 1B Adrenergic Receptor (Alpha 1B Adrenoreceptor or ADRA1B) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Alpha 1B Adrenergic Receptor (Alpha 1B Adrenoreceptor or ADRA1B) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Alpha 1B Adrenergic Rece...

May 2022 37 pages

Alpha 2 Adrenergic Receptor (ADRA2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Alpha 2 Adrenergic Receptor (ADRA2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Alpha 2 Adrenergic Receptor (ADRA2) Drugs in Developm...

May 2022 68 pages

Alpha Adrenergic Receptor (ADRA) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Alpha Adrenergic Receptor (ADRA) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Alpha Adrenergic Receptor (ADRA) Drugs in Development by...

May 2022 101 pages

Alport Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Alport Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Alport Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players...

May 2022 42 pages

Amine Oxidase [Flavin Containing] A (Monoamine Oxidase Type A or MAOA or EC 1.4.3.4) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Amine Oxidase [Flavin Containing] A (Monoamine Oxidase Type A or MAOA or EC 1.4.3.4) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Amin...

May 2022 39 pages

Amine Oxidase [Flavin Containing] B (Monoamine Oxidase Type B or MAOB or EC 1.4.3.4) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Amine Oxidase [Flavin Containing] B (Monoamine Oxidase Type B or MAOB or EC 1.4.3.4) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Amin...

May 2022 52 pages

Amino Acid Metabolism Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Amino Acid Metabolism Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Amino Acid Metabolism Disorders Drugs in Development by Stages, Target, MoA, RoA...

May 2022 107 pages

Anal Fissure Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Anal Fissure Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Anal Fissure Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provid...

May 2022 37 pages

Anaplastic Large Cell Lymphoma (ALCL) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Anaplastic Large Cell Lymphoma (ALCL) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Anaplastic Large Cell Lymphoma (ALCL) Drugs in Development by Stages, Targ...

May 2022 112 pages

Anaplastic Thyroid Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Anaplastic Thyroid Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Anaplastic Thyroid Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule T...

May 2022 64 pages

Androgen Receptor (Dihydrotestosterone Receptor or Nuclear Receptor Subfamily 3 Group C Member 4 or DHTR or NR3C4 or AR) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 3,500.00

Androgen Receptor (Dihydrotestosterone Receptor or Nuclear Receptor Subfamily 3 Group C Member 4 or DHTR or NR3C4 or AR) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecu...

May 2022 136 pages

Androgen-Sensitive Prostate Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Androgen-Sensitive Prostate Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Androgen-Sensitive Prostate Cancer Drugs in Development by Stages, Target, Mo...

May 2022 35 pages

Androgenic Alopecia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Androgenic Alopecia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Androgenic Alopecia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key...

May 2022 52 pages

Anemia of Chronic Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Anemia of Chronic Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Anemia of Chronic Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule T...

May 2022 35 pages

Angelman Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Angelman Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Angelman Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Play...

May 2022 53 pages

Angioimmunoblastic T-Cell Lymphoma (AITL)-Immunoblastic Lymphadenopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Angioimmunoblastic T-Cell Lymphoma (AITL)-Immunoblastic Lymphadenopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Angioimmunoblastic T-Cell Lymphoma (AITL...

May 2022 96 pages

Angiopoietin 2 (Ang 2 or ANGPT2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Angiopoietin 2 (Ang 2 or ANGPT2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Angiopoietin 2 (Ang 2 or ANGPT2) Drugs in Development by...

May 2022 47 pages

Angiopoietin Related Protein 3 (Angiopoietin 5 or Angiopoietin Like Protein 3 or ANG 5 or ANGPTL3) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Angiopoietin Related Protein 3 (Angiopoietin 5 or Angiopoietin Like Protein 3 or ANG 5 or ANGPTL3) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Player...

May 2022 39 pages

Angiosarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Angiosarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Angiosarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provid...

May 2022 64 pages

Angiotensin Converting Enzyme (Dipeptidyl Carboxypeptidase I or Kininase II or CD143 or ACE or EC 3.4.15.1 or EC 3.2.1.) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Angiotensin Converting Enzyme (Dipeptidyl Carboxypeptidase I or Kininase II or CD143 or ACE or EC 3.4.15.1 or EC 3.2.1.) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecu...

May 2022 45 pages

Anorexia Nervosa Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Anorexia Nervosa Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Anorexia Nervosa Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Player...

May 2022 41 pages

Anterior Uveitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Anterior Uveitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Anterior Uveitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Player...

May 2022 41 pages

Anthrax Protective Antigen (pa) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Anthrax Protective Antigen (pa) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Anthrax Protective Antigen (pa) Drugs in Development by T...

May 2022 38 pages

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Anti-Neutrophil Cytoplasmic Antibod...

May 2022 55 pages

Antiphospholipid Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Antiphospholipid Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Antiphospholipid Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule T...

May 2022 36 pages

Antithrombin III (ATIII or SERPINC1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Antithrombin III (ATIII or SERPINC1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Antithrombin III (ATIII or SERPINC1) Drugs in Develo...

May 2022 40 pages

Anxiety Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Anxiety Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Anxiety Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Play...

May 2022 243 pages

Aortic Valve Stenosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Aortic Valve Stenosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Aortic Valve Stenosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and...

May 2022 38 pages

Apolipoprotein A (APOA or LPA) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Apolipoprotein A (APOA or LPA) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Apolipoprotein A (APOA or LPA) Drugs in Development by The...

May 2022 42 pages

Apolipoprotein A I (APOA1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Apolipoprotein A I (APOA1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Apolipoprotein A I (APOA1) Drugs in Development by Therapy Are...

May 2022 37 pages

Apolipoprotein C III (APOC3) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Apolipoprotein C III (APOC3) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Apolipoprotein C III (APOC3) Drugs in Development by Therapy...

May 2022 40 pages

Apolipoprotein E (APOE) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Apolipoprotein E (APOE) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Apolipoprotein E (APOE) Drugs in Development by Therapy Areas and...

May 2022 47 pages

Apolipoprotein L1 (Apolipoprotein L or APOL1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Apolipoprotein L1 (Apolipoprotein L or APOL1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Apolipoprotein L1 (Apolipoprotein L or APOL...

May 2022 35 pages

Apoptosis Regulator Bcl 2 (Protein Phosphatase 1 Regulatory Subunit 50 or BCL2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Apoptosis Regulator Bcl 2 (Protein Phosphatase 1 Regulatory Subunit 50 or BCL2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Apoptosis...

May 2022 42 pages

Appetite (Eating) Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Appetite (Eating) Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Appetite (Eating) Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecu...

May 2022 67 pages

Aquaporin 4 (Mercurial Insensitive Water Channel or WCH4 or AQP4) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Aquaporin 4 (Mercurial Insensitive Water Channel or WCH4 or AQP4) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Aquaporin 4 (Mercurial...

May 2022 36 pages

Arachidonate 15 Lipoxygenase (12-15 Lipoxygenase or Arachidonate 12 Lipoxygenase Leukocyte Type or Arachidonate Omega 6 Lipoxygenase or ALOX15 or EC 1.13.11.33 or EC 1.13.11.31) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Arachidonate 15 Lipoxygenase (12-15 Lipoxygenase or Arachidonate 12 Lipoxygenase Leukocyte Type or Arachidonate Omega 6 Lipoxygenase or ALOX15 or EC 1.13.11.33 or EC 1.13.11.31) Drugs in Development b...

May 2022 36 pages

Arachidonate 5 Lipoxygenase (5 Lipoxygenase or Leukotriene A4 Synthase or ALOX5 or EC 1.13.11.34) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Arachidonate 5 Lipoxygenase (5 Lipoxygenase or Leukotriene A4 Synthase or ALOX5 or EC 1.13.11.34) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players...

May 2022 42 pages